IP Verse

Abbvie Biotechnology competitive analysis

Discover the latest PTAB cases involving Abbvie Biotechnology, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 1, 2026

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Abbvie Biotechnology
IPR2018-00156	Nov 6, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2018-00002	Oct 2, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-02105	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled
IPR2017-02106	Sep 14, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Terminated-Settled
IPR2017-01987	Aug 21, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01988	Aug 21, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01823	Jul 20, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01824	Jul 20, 2017	SANDOZ	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01008	Mar 2, 2017	COHERUS BIOSCIENCES	ABBVIE BIOTECHNOLOGY	Institution Denied
IPR2017-01009	Mar 2, 2017	COHERUS BIOSCIENCES	ABBVIE BIOTECHNOLOGY	Institution Denied

IP litigation analysis comparing Abbvie Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ABBVIE BIOTECHNOLOGY	-	-	-	22
AMGEN	8	138	8	11
COHERUS BIOSCIENCES	-	-	12	1
SANDOZ	122	16	19	-